100%(1)100% menganggap dokumen ini bermanfaat (1 suara)
86 tayangan13 halaman
"Aseptic processing" is the production of sterile drug products. The process involves bringing together the product, container, and closure that have been subjected to different sterilization methods separately, and assembled them in an extremely high quality environment by skilled personnel using the right tools.
"Aseptic processing" is the production of sterile drug products. The process involves bringing together the product, container, and closure that have been subjected to different sterilization methods separately, and assembled them in an extremely high quality environment by skilled personnel using the right tools.
"Aseptic processing" is the production of sterile drug products. The process involves bringing together the product, container, and closure that have been subjected to different sterilization methods separately, and assembled them in an extremely high quality environment by skilled personnel using the right tools.
Discussion WCC PDA Dinner Meeting November 30 th , 2006
Jennifer Cheung Genentech, Inc. What is Aseptic Processing? The production of sterile drug products by bringing together the product, container, and closure that have been subjected to different sterilization methods separately, and assembled them in an extremely high quality environment by skilled personnel using the right tools. Aseptic Processing: Essential Elements Documentation Finish Product Testing Control & Verification Personnel Process Equipment Facility Aseptic Processing Aseptic Processing: Essential Elements Facility Design Zoning, Differential Pressure Temperature Relative Humidity Personnel and Material Flow Air Filtration Equipment Material of Construction Sanitization Component Preparation/Sterilization Aseptic Processing: Essential Elements Process Product Formulation Filtration Filling Lyophilization Capping Personnel Gowning Qualification Aseptic Technique Control and Verification Environmental and Personnel Monitoring Aseptic Filling Simulations (Media Fills)
Aseptic Processing: Essential Elements Finished Product Testing Sterility Testing Particulate Testing Container Closure Integrity Testing Other Final Product/Release Testing Stability Testing Documentation Media Fill Records Production Batch Records EM Trend Data Release Testing Batch Records Investigation Response to Excursions Corrective Actions Sterility Testing Monitoring of aseptic processing Compendial requirement US Pharmacopoeia European Pharmacopoeia British Pharmacopoeia Japanese Pharmacopoeia Code of Federal Regulations Test methods became harmonized with the publication of the BP 2004, Ph Eur 5.1 and USP 28 editions Sterility Testing Method Overview Limited number of samples: 4 to 20 containers per medium for parenteral preparations Limited volume for analysis: Not less than 1mL for 1-40mL containers; not less than 20mL for >40mL containers 2 Media: Soybean-Casein Digest Medium and Fluid Thioglycollate Medium 2 Temperatures: 22.5 + 2.5 C and 32.5 + 2.5 C 14 days of incubation Inspect for evidence of microbial growth (turbidity)
Simple, or not so simple? Incubation Incubate for 14 days 14 days? Or 14 x 24 hours? Why is the maximum incubation for bacteria 3 days in growth promotion test and 5 days in validation of sterility test? After all, why isnt the maximum incubation be 14 days? Method Validation Should validation of sterility test be repeated at each testing location for the same product, when testing methodology is the same? Is revalidation of sterility testing methodology necessary? If so, at frequency? Every 12 months? Can bulk material be used as a substitute for final vials in the validation of sterility test? How many firms use environmental/process isolates in the validation of sterility test?
Simple, or not so simple? Method Monitoring How many firms perform stasis test (i.e. monitoring the efficacy of test media at the end of the incubation period)? How often should stasis test be performed on each product? Sample/Sampling Plan Is bulk sterility testing, as required by CFR for biologics, an absolute requirement for biotech products? Sampling plan for final product: Beginning, middle, end; or randomly throughout the entire batch? How to obtain 20 representative samples for a >10000 vials fill? Qualification of Personnel How to qualify a sterility tester? Re-qualification of testers? How often? Interpretation of Result is Simple USP These Pharmacopeial procedures are not by themselves designed to ensure that a batch of product is sterile or has been sterilized. This is accomplished primarily by validation of the sterilization process or of the aseptic processing procedures. When evidence of microbial contamination of the article is obtained by the appropriate Pharmacopeial methods, the result so obtained is conclusive evidence of failure of the article to meet the requirements of the test for sterility, even if a different result is obtained by an alternative procedure. FDA Guidance for Industry A sterility positive result can be viewed as indicative of production or laboratory problems, and the entire manufacturing process should be comprehensively investigated since such problems often can extend beyond a single batch. To invalidate a positive sterility test is extremely difficult, if not impossible. Quality should be built into the product, and testing alone cannot be relied on to ensure product quality.
Media Fills Validation of aseptic processing True parameter for assuring that a manufacturing process is capable of producing sterile pharmaceuticals using an aseptic process. Media fill program provides evaluation of multiple systems.
Sterility Test Versus Media Fill Sterility Test Media Fill Guidance Documents FDA Guidance for Industry Code of Federal Regulations Multiple Pharmacopeia FDA Guidance for Industry EU Guide to Good Manufacturing Practice Revision to Annex 1 Sample size/Lot Maximum 40 All Media Soybean-Casein Digest Medium (TSB) Fluid Thioglycollate Medium (FTM) Soybean-Casein Digest Medium (TSB) Incubation conditions TSB 14 days @ 20-25C FTM 14 days @ 30-35C TSB 7 days @ 20-25C TSB 7 days @ 30-35C Growth promotion Yes Yes Test method Destructive: Sample contents transferred Non-destructive: Integral container Sensitivity False positives Detects high level sterility failure No false positives Detects single vial failure